# 6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

> **NCT07198685** · NA · NOT_YET_RECRUITING · sponsor: **Wuhan Pulmonary Hospital** · enrollment: 52 (estimated)

## Conditions studied

- Treat to Target
- Treatment Duration

## Interventions

- **DRUG:** bedaquiline
- **DRUG:** Delamanid (DLM)
- **DRUG:** Linezolid (LZD)
- **DRUG:** Levofloxacin
- **DRUG:** Cycloserine
- **DRUG:** Clofazimine

## Key facts

- **NCT ID:** NCT07198685
- **Lead sponsor:** Wuhan Pulmonary Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07198685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07198685, "6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07198685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*